Opinion: STAT+: Making pharma’s post-Covid-19 future faster and smarter

There’s nothing like a global pandemic to force a reimagining of one’s business. What it means for the pharmaceutical industry is that it can’t keep doing what it’s been doing for years.

Covid-19 has exposed the industry’s antiquated sales model and revealed the limitations and opportunities of remote commerce. And the speed with which Covid-19 vaccines have been developed taught us that bringing therapies to market needn’t be a 10-year slog if you’re working in concert with government for the betterment of public health.

Continue to STAT+ to read the full story…

Opinion: STAT+: Making pharma’s post-Covid-19 future faster and smarter

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top